Ocugen, Inc. (OCGN) Cash Flow Statement
Ocugen, Inc. (OCGN) generated -$60.9M of operating cash flow over the twelve months to 2026-06-30, spent $153000 on capital expenditure and had free cash flow of -$61.0M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OCGNOcugen, Inc.Follow OCGN — free
—
Price chart with a free account
- Market cap
- 250.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2020 Dec 20 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -14.7 | -60.1 | -62.1 | -42.1 | -57.0 | -60.9 | |
| Capital expenditure | 0.3 | 4.5 | 10.5 | 3.4 | 0.2 | -0.2 | |
| Free cash flow | -15.0 | -64.5 | -72.5 | -45.5 | -57.1 | -61.0 | |
| Share repurchases | 0.0 | — | — | — | — | — |
USD millions · SEC XBRL
Ocugen, Inc. — questions
- What is Ocugen, Inc.'s operating cash flow?
- -$60.9M over the twelve months to 2026-06-30.
- How much does Ocugen, Inc. spend on capital expenditure?
- $153000 over the twelve months to 2026-06-30.
- What is Ocugen, Inc.'s free cash flow?
- -$61.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Ocugen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.